Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Social Media Network for Heart Failure Patients in Development by Novartis

XTALKS VITALS NEWS

Social Media

According to Novartis, it is “the first dedicated social network for people to share their stories, support and inspire each other.”

Share this!

November 18, 2016 | by Sarah Hand, M.Sc.

Earlier this month, Novartis Pharmaceutical launched a social media community aimed at bringing heart failure patients and their caregivers together. According to Novartis, it is “the first dedicated social network for people to share their stories, support and inspire each other.”

The site – named, ‘Together in HF’ – is a free resource for both heart failure information and support. The community allows users to contribute content, and comment on other members’ posts.

Heart failure affects almost six million Americans, and Novartis hopes that the social media network will increase awareness of the condition. The platform is also set to be available as an app, with the iOS version expected to be launched in early 2017.



“Together in HF is a collective effort that brings together the expertise and resources of many organizations with a special focus on the unique social and emotional needs of people who are living with heart failure,” said Fabrice Chouraqui, Novartis president. Together in HF reportedly has around 500 members.

According to a spokesperson for Novartis, the company worked for over two years on the social community, at which time they worked closely with patient and caregiver advocacy groups, along with medical societies. They were specifically interested in learning about both the social and emotional needs of heart failure patients and their caregivers, in order to ensure the platform offered more than existing communities.

“Through working with the HF community, we discovered that patients and caregivers were burdened by the emotional aspects of HF and needed an environment where they could meet and share their stories with others who had similar experiences,” a Novartis spokesperson told BioPharma Dive. The American Association of Heart Failure Nurses, Association of Black Cardiologists, CardioSmart by the American College of Cardiology, Mended Hearts, and the National Alliance for Caregiving, are all founding members of the platform.

“It is often these less tangible effects of the condition that are overshadowed by the physical signs,” said Mary McGowan, CEO of another partnering organization, WomenHeart. “Yet we know that focusing on the whole patient experience greatly contributes to the overall health of the patient.”


Keywords: Social Media, Heart Failure, Caregiver


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
New Self-Injectable Form of Lupus Drug Approved by the FDA

July 25, 2017 - Patients with systemic lupus erythematosus (SLE) will now have the option to self-inject their medication thanks to the FDA approval of GSK’s reformulated lupus drug, Benlysta (belimumab).

Featured In: Biotech News


Canadian Chicken Farmers to Further Reduce Use of Antibiotics

July 24, 2017 - The Chicken Farmers of Canada, a national group dedicated to supporting poultry farmers and helping them meet consumer demand for chicken, has announced their strategy for eliminating the use of certain antimicrobials in meat production.

Featured In: Food News


Neonatal MRI Medical Device Approved by the FDA

July 24, 2017 - Medical device maker Aspect Imaging has received US Food and Drug Administration (FDA) approval for its Embrace Neonatal MRI System.

Featured In: Medical Device News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know

REGISTER FOR THESE WEBINARS

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.